Meet QRD Pharma at “Molecule to Market” – May 29th, Philadelphia
Our leadership team will be attending the upcoming “Molecule to Market” event on May 29th at 2300 Market Street, Philadelphia. We invite you to connect with our Founder and CEO Venkatraman Junnotula, to explore how QRD Pharma can support your research journey—from early discovery all the way to product launch.
QRD Pharma is a science-driven contract research organization (CRO) specializing in LC-MS-based bioanalytical services. Our expertise enables us to deliver high-quality data and insights that accelerate drug development.
To learn more about how we can partner with you, contact us at [email protected].
